Search clinical trials for: Leuprorelin acetate

Total 3978 results

Zodiac Produtos Farmaceuticos S.A.

Completed

Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. (PRIZE)

Prostate Cancer

Brazil
CuraGen Corporation

Completed

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Unresectable Stage III or Stage IV Melanoma

United States
AbbVie

Completed

Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis

Endometriosis
Karolinska Institutet

Completed

Hemodynamic Effects of Cold Versus Warm Fluid Bolus

Temperature Change, Body | Hypovolemia

Sweden
AbbVie (prior sponsor, Abbott)

Completed

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Central Precocious Puberty (CPP) | Precocious | Leuprolide Acetate | Luteinizing Hormone (LH) | Gonadotrophin-releasing Hormone Agonist (GnRHa) | Tanner Staging | Depot Formulation | Suppression of LH | Gonadotrophin-releasing Hormone (GnRH) | Lupron | GnRH Analog | Pediatrics Central Precocious Puberty

United States, Puerto Rico
Takeda

Recruiting

A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

Central Precocious Puberty

China
Wonju Severance Christian Hospital
Eulji University Hospital

Recruiting

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Prostatic Neoplasms

Korea, Republic of
Parc de Salut Mar

Completed

Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control

There Are no Conditions Under Study. Healthy Volunteers
UNICANCER
Astellas Pharma Inc

Active, not recruiting

Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.

Metastases

France
Peptron, Inc.

Not yet recruiting

To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers

Prostate Cancer
Astellas Pharma Europe Ltd.

Terminated

A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease (EFFECT)

Metastatic Prostate Cancer

Netherlands
Cancer Research Antwerp
Bayer; Veracyte, Inc.

Recruiting

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER)

Prostate Cancer

Belgium
Astellas Pharma Inc

Completed

A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD (ICELAND)

Prostate Cancer

Belgium, France, Spain, Italy, Hungary, Russian Federation, Germany, Slovakia, Finland, Czech Republic
Sidney Kimmel Cancer Center at Thomas Jefferson...
Astellas Pharma Inc; Medivation, Inc.

Active, not recruiting

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Recurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate Cancer

United States
Astellas Pharma Europe B.V.

Completed

An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

Advanced Prostate Carcinoma

Russian Federation
Kissei Pharmaceutical Co., Ltd.

Completed

Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis

Endometriosis

Japan
Takeda

Completed

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Breast Cancer
National Taiwan University Hospital
Debiopharm International SA; Ministry of Health and Welfare

Not yet recruiting

Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients (ESCALATE)

Triple Negative Breast Cancer | Premenopausal Breast Cancer
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain

Endometriosis

Belgium, Bulgaria, Germany, Hungary, Japan, Poland, Romania, Ukraine, United Kingdom
Takeda

Completed

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Premenopausal Breast Cancer

Japan
Takeda

Completed

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"

Prostate Cancer
Takeda

Completed

Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"

Prostate Cancer

Japan
Takeda

Recruiting

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

Spinal and Bulbar Muscular Atrophy

Japan
Takeda

Completed

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Breast Cancer
Cancer Research Antwerp
Janssen Pharmaceutica

Recruiting

Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (SAVE)

Cancer of Prostate

Belgium
Astellas Pharma Inc

Completed

Retrospective, Non-interventional Study of Depo-Eligard®. (OCT)

Prostate Cancer

Belgium
Joachim Zdolsek

Recruiting

Fluid Challenge and Plasma Volume, During Surgery (FC-VE)

Gynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign Neoplasm

Sweden
Trans Tasman Radiation Oncology Group
National Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaborators

Completed

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Prostate Cancer

Australia, New Zealand
Centre of Experimental Medicine
Millennium Pharmaceuticals, Inc.

Terminated

A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone (NEPTUNE)

Prostate Cancer

United Kingdom
Weill Medical College of Cornell University

Withdrawn

Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients (OMLET)

Infertility

United States
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Ministry of Health, France; Ministry...

Terminated

Comparison of Two Pharmacological Treatments of Pedophilia (PCNET)

Pedophilia

France
ASKA Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

Endometriosis

Japan
Children's Hospital of Fudan University

Completed

Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine

Idiopathic Precocious Puberty

China
Takeda

Completed

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Uterine Fibroids
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
Ruijin Hospital
Shanghai Children's Hospital; Shanghai Children's Medical Center; Xin Hua Hospital

Completed

Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty

Central Precocious Puberty
Abbott

Completed

A Study of Leuprolide to Treat Prostate Cancer

Prostate Cancer

United States
Wendell Yap, MD
University of Kansas Medical Center

No longer available

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan

Prostate Cancer

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Active, not recruiting

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Prostate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate Cancer

Canada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
Takeda

Completed

Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

Endometriosis

Japan
Takeda

Completed

A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis

Endometriosis

Japan
University of Michigan
National Institutes of Health (NIH)

Completed

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Heart Failure | Cardiomyopathies

United States
Fudan University

Not yet recruiting

RWE About QOL and Compliance of Patients With OFS in China

Quality of Life | Breast Cancer | Hormone Receptor-positive Breast Cancer

China
Uppsala University

Terminated

Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients

Postoperative Complications | Fluid Therapy | Fluid Overload | Pancreas Disease | Postoperative Period

Sweden
Jonsson Comprehensive Cancer Center

No longer available

C11 Sodium Acetate PET/CT Imaging of PCa

Prostate Cancer

United States
Takeda

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids

Uterine Fibroids

Japan
Daniel Vaena

Completed

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

Prostate Cancer | Castrate Resistant Prostate Cancer

United States
Vanderbilt University Medical Center

Completed

Balanced Solutions and Plasma Electrolytes (BASE)

Critical Illness | Acidosis, Metabolic

United States
Phoenix Molecular Imaging

Completed

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Prostate Cancer

United States
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States

Search clinical trials for: Leuprorelin acetate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations